• 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)
  • 2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)

2019-nCoV Spike S1 protein (C-His&Avi) (STJP000022)

SKU:
STJP000022-100

Shipping:
Free Shipping
Current Stock:
Host: HEK293 cells
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: 2019-nCoV Spike S1-C-His&Avi protein was developed from hek293 cells and has a target region of C-His&Avi. For use in research applications.
Formulation: Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. or Supplied as a 0.22 Mu m filtered solution in PBS, pH 7.4. Contact us for customized product form or formulation.
Immunoreactivity: Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Spike S1 at 2 Mu g/mL (100 Mu L/well) can bind recombinant Human ACE2 with a linear range of 0.15-6.85 ng/mL.2. Immobilized Human ACE2 on COOH Chip can bind SAR
Immunogen Region: Gln14-Arg683
Immunogen: Recombinant SARS-CoV-2 (2019-nCoV) Spike S1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-COV-2 (2019-nCoV) Spike S1 (Accession #YP_009724390.1) fused with a 6×His tag and
Background Recombinant SARS-CoV-2 (2019-nCoV) Spike S1 Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Gln14-Arg683) of SARS-COV-2 (2019-nCoV) Spike S1 (Accession #YP_009724390.1) fused with a 6×His tag and Avi at the C-terminus.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance